Search by Drug Name or NDC
NDC 70752-0161-11 PHENOBARBITAL 16.2 mg/1 Details
PHENOBARBITAL 16.2 mg/1
PHENOBARBITAL is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by QUAGEN PHARMACEUTICALS LLC. The primary component is PHENOBARBITAL.
MedlinePlus Drug Summary
Phenobarbital is used to control seizures. Phenobarbital is also used to relieve anxiety. It is also used to prevent withdrawal symptoms in people who are dependent ('addicted'; feel a need to continue taking the medication) on another barbiturate medication and are going to stop taking the medication. Phenobarbital is in a class of medications called barbiturates. It works by slowing activity in the brain.
Related Packages: 70752-0161-11Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Phenobarbital
Product Information
| NDC | 70752-0161 |
|---|---|
| Product ID | 70752-161_234e0cf8-e1c9-47a2-8fa3-8a4db929c866 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | PHENOBARBITAL |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PHENOBARBITAL |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 16.2 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENOBARBITAL |
| Labeler Name | QUAGEN PHARMACEUTICALS LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | CIV |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70752-0161-11 (70752016111)
| NDC Package Code | 70752-161-11 |
|---|---|
| Billing NDC | 70752016111 |
| Package | 1000 TABLET in 1 BOTTLE (70752-161-11) |
| Marketing Start Date | 2020-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |